ARROWHEAD PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2017 to Q4 2023.
  • Arrowhead Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$118M, a 56% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$154M, a 13% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$136M, a 179% decline from 2021.
  • Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $171M.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$118M -$42.3M -56% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q4 2022 -$75.5M -$14.2M -23.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q4 2021 -$61.3M -$22.4M -57.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-06
Q4 2020 -$38.9M -$15.4M -65.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q4 2019 -$23.5M -$192M -114% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q4 2018 $168M +$183M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-05
Q4 2017 -$14.7M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.